These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 626985)

  • 1. Enhancement by Corynebacterium parvum of the normal and tumor tissue response to hyperthermia.
    Urano M; Overgaard M; Suit H; Dunn P; Sedlacek R
    Cancer Res; 1978 Mar; 38(3):862-4. PubMed ID: 626985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the thermal response of animal tumors by Corynebacterium parvum.
    Urano M; Suit HD; Dunn P; Lansdale T; Sedlacek RS
    Cancer Res; 1979 Sep; 39(9):3454-7. PubMed ID: 476675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of thermal response of normal and malignant tissues by Corynebacterium parvum.
    Urano M; Yamashita T; Suit HD; Gerweck LE
    Cancer Res; 1984 Jun; 44(6):2341-7. PubMed ID: 6722772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
    Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
    Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of thermochemotherapy (combined cyclophosphamide and hyperthermia) given at various temperatures with or without glucose administration on a murine fibrosarcoma.
    Urano M; Kim MS; Kahn J; Kenton LA; Li ML
    Cancer Res; 1985 Sep; 45(9):4162-6. PubMed ID: 4028008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of interleukin-10 at the time of priming protects Corynebacterium parvum-primed mice against LPS- and TNF-alpha-induced lethality.
    Smith SR; Terminelli C; Denhardt G; Narula S; Thorbecke GJ
    Cell Immunol; 1996 Nov; 173(2):207-14. PubMed ID: 8912878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
    Murata R; Horsman MR
    Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of Corynebacterium parvum on the immune response in guinea pigs. I. Mode of enhancement of the anamnestic response and development of delayted hypersensitivity after treatment with Corynebacterium parvum].
    Halpern B; Gauthier-Rahman S; Besluau D
    C R Seances Soc Biol Fil; 1977; 171(6):1202-8. PubMed ID: 148948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 42 degrees C hyperthermia on murine normal and tumor tissues.
    Urano M; Kahn J
    Cancer Res; 1985 Jun; 45(6):2527-32. PubMed ID: 3986792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of step-down heating on murine normal and tumor tissues.
    Urano M; Kahn J
    Radiat Res; 1983 May; 94(2):350-8. PubMed ID: 6856779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel and hyperthermia: factors that modify thermal enhancement.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    J Surg Oncol; 2004 Oct; 88(1):14-20. PubMed ID: 15384091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced resistance of mice to Mycoplasma pulmonis-induced arthritis by administration of killed Corynebacterium parvum.
    Keystone EC; Taylor-Robinson D; Ling L; Pope C; Metcalfe A; Furr P; Fornasier V
    Clin Exp Immunol; 1981 Nov; 46(2):355-62. PubMed ID: 7337973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of C3H mice bearing solid Gardner lymphosarcoma with vaccine prepared from Corynebacterium parvum combined with methotrexate and Alexan.
    Motycka K; Chudomel V; Bednár M; Bostík J
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):413-9. PubMed ID: 6549500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumor effect of Corynebacterium parvum on C3H mouse bearing MH-134 tumor].
    Nakamura K; Miwa H; Hashimoto O; Inoue T; Orita K
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1046-51. PubMed ID: 7184438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological enhancement of leukemia L1210 by Corynebacterium parvum in allogeneic mice.
    Berd DA; Mitchell MS
    Cancer Res; 1976 Nov; 36(11 Pt 1):4119-24. PubMed ID: 975053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin.
    Satoh M; Inagawa H; Shimada Y; Soma G; Oshima H; Mizuno D
    J Biol Response Mod; 1987 Oct; 6(5):512-24. PubMed ID: 2445926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vaccine prepared from Corynebacterium parvum on the growth of Gardner lymphosarcoma in C3H strain mice.
    Motycka K; Chudomel V; Bednár M; Bostík J
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):405-12. PubMed ID: 6549499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunological activities of components isolated from Corynebacterium parvum in mice injected with polyoma tumor cells.
    Tomecki J; Mara M
    Neoplasma; 1987; 34(1):15-22. PubMed ID: 3031518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitumor effect of Corynebacterium parvum].
    Mazurek C; Chalvet H; Biozzi G; Stiffel C
    Ann Immunol (Paris); 1977; 128(1-2):161-3. PubMed ID: 576780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.